… the Company has bolstered its intellectual property (“IP”) portfolio by securing various IP rights. G6 has filed a provisional patent application to secure its proprietary technology of manufacturing antiviral products. Further, the Company has received approvals from the U.S. Patent and Trademark Office (“USPTO”) for a patent covering the technology of making graphene-based energy storage devices by additive manufacturing as well as a patent covering multisegmented 3D printing filaments.